DMB-I in the Treatment of Alzheimer Type Dementia
Phase 2
Completed
- Conditions
- Dementia of Alzheimer TypeAlzheimer Disease
- Interventions
- Drug: DMB-I (Dimebon)Other: Placebo
- First Posted Date
- 2024-03-05
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Bigespas LTD
- Target Recruit Count
- 133
- Registration Number
- NCT06292351
- Locations
- 🇷🇺
"Medical Center Nova Vita", Rostov-on-Don, Russian Federation
🇷🇺State autonomous healthcare institution "Transregional Clinical Diagnostic Center", Kazan, Russian Federation
🇷🇺Federal State Budgetary Institution "Federal center for brain and neurotechnologies" of the Federal Medical and Biological Agency (FSBI "FCBN" of Russia's FMBA), Moscow, Russian Federation
© Copyright 2025. All Rights Reserved by MedPath